Cancer and cyclooxygenase-2 (COX-2) inhibition

JF Evans, SL Kargman - Current pharmaceutical design, 2004 - ingentaconnect.com
Prior to the discovery of cyclooxygenase-2 (COX-2), a beneficial association was shown
between chronic usage of non steroidal anti-inflammatory drugs (NSAIDs), that …
被引用次数：92 相关文章

Cancer and Cyclooxygenase-2 (COX-2) Inhibition

JF Evans, SL Kargman - Current Pharmaceutical Design, 2004 - search.proquest.com
Prior to the discovery of cyclooxygenase-2 (COX-2), a beneficial association was shown
between chronic usage of non steroidal anti-inflammatory drugs (NSAIDs), that …

Cancer and cyclooxygenase-2 (COX-2) inhibition.

JF Evans, SL Kargman - Current Pharmaceutical Design, 2004 - europepmc.org
Prior to the discovery of cyclooxygenase-2 (COX-2), a beneficial association was shown
between chronic usage of non steroidal anti-inflammatory drugs (NSAIDs), that non …

[引用][C] Cancer and cyclooxygenase-2 (COX-2) inhibition

E JF - Curr Pharm Des, 2004 - cir.nii.ac.jp
Cancer and cyclooxygenase-2 (COX-2) inhibition | CiNii Research CiNii 国立情報学研究所 学術
情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本を …

[引用][C] Cancer and cyclooxygenase-2 (COX-2) inhibition: New insight into COX-2 biology and inhibition

JF EVANS, SL KARGMAN - Current pharmaceutical design, 2004 - pascal-francis.inist.fr
Cancer and cyclooxygenase-2 (COX-2) inhibition : New insight into COX-2 biology and
inhibition CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …

Cancer and cyclooxygenase-2 (COX-2) inhibition

JF Evans, SL Kargman - Current pharmaceutical design, 2004 - pubmed.ncbi.nlm.nih.gov
Prior to the discovery of cyclooxygenase-2 (COX-2), a beneficial association was shown
between chronic usage of non steroidal anti-inflammatory drugs (NSAIDs), that non …

[引用][C] Cancer and cyclooxygenase-2 (COX-2) inhibition: New insight into COX-2 biology and inhibition

JF EVANS, SL KARGMAN - Current pharmaceutical design, 2004 - Bentham